PFS - AstraZeneca's Enhertu buoyed by progression-free survival data in breast cancer
2024-04-29 08:29:05 ET
More on AstraZeneca
- AstraZeneca: A Triple Shot Of Income, Growth, And Value
- AstraZeneca: Strong In A Weak Market
- AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript
- J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade
- AstraZeneca rises as oncology business drives Q1 beat